comparemela.com

Latest Breaking News On - Technol ther - Page 1 : comparemela.com

New Real-World Data Shows Minimedtm 780G System Sustains Strong Global Performance, Exceeding International Targets For Diabetes Management

New Real-World Data Shows Minimedtm 780G System Sustains Strong Global Performance, Exceeding International Targets For Diabetes Management
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Ireland
Italy
Arkansas
United-states
Dublin
United-kingdom
Netherlands
Belgium
Sweden
American
Prnewswire-medtronic
El-malahi

New real-world data shows MiniMed™ 780G system maintains strong performance globally and exceeds international goals for diabetes management

New real-world data shows MiniMed™ 780G system maintains strong performance globally and exceeds international goals for diabetes management
independantexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from independantexpress.com Daily Mail and Mail on Sunday newspapers.

Arkansas
United-states
Netherlands
Sweden
Italy
Belgium
American
Medtronic
El-malahi
Van-elsen
Robert-bigarsky
American-diabetes-association

New real-world data shows MiniMed™ 780G system sustains strong global performance, exceeding international targets for diabetes management

New real-world data shows MiniMed™ 780G system sustains strong global performance, exceeding international targets for diabetes management
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Ireland
Dublin
Arkansas
United-states
Netherlands
Sweden
Italy
Belgium
American
Robert-vigersky
Ryan-weispfenning
El-malahi

Type 1 diabetes

Type 1 diabetes is a chronic disease caused by autoimmune destruction of pancreatic β cells. Individuals with type 1 diabetes are reliant on insulin for survival. Despite enhanced knowledge related to the pathophysiology of the disease, including interactions between genetic, immune, and environmental contributions, and major strides in treatment and management, disease burden remains high. Studies aimed at blocking the immune attack on β cells in people at risk or individuals with very early onset type 1 diabetes show promise in preserving endogenous insulin production.

Vestergaard
Syddanmark
Denmark
Lampeter
Ceredigion
United-kingdom
Herrath
Nordrhein-westfalen
Germany
Wasserfall
Pathiraja
Central

The impact of the COVID-19 pandemic on diabetes services: planning for a global recovery

The COVID-19 pandemic has disproportionately affected certain groups, such as older people (ie, >65 years), minority ethnic populations, and people with specific chronic conditions including diabetes, cardiovascular disease, kidney disease, and some respiratory diseases. There is now evidence of not only direct but also indirect adverse effects of COVID-19 in people with diabetes. Recurrent lockdowns and public health measures throughout the pandemic have restricted access to routine diabetes care, limiting new diagnoses, and affecting self-management, routine follow-ups, and access to medications, as well as affecting lifestyle behaviours and emotional wellbeing globally.

Brazil
New-york
United-states
Japan
Copenhagen
Køavn
Denmark
Hong-kong
Motoshima
Akagawa
United-kingdom
Seidu

vimarsana © 2020. All Rights Reserved.